Skip to main content

Table 2 Baseline characteristics of NSCLC patients according to RDW

From: Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

Variables

Total

RDW ≤ 12.9

RDW > 12.9

p-value                                                       

Age (years)

58.0 ± 8.4

57.9 ± 8.4

58.3 ± 8.3

0.631

BMI (kg/m2)

24.1 ± 3.3

24.3 ± 3.2

23.7 ± 3.4

0.091

WBC (×109/L)

6.54 ± 2.11

6.42 ± 1.87

6.80 ± 2.56

0.160

Hemoglobin (g/dl)

142.8 ± 14.3

144.8 ± 13.2

138.4 ± 15.8

< 0.001

Platelet count (×109/L)

240.8 ± 69.4

238.0 ± 68.2

247.2 ± 72.1

0.234

NLR

2.26 ± 2.58

2.03 ± 1.16

2.78 ± 4.29

0.066

PLR

132.4 ± 73.9

127.8 ± 49.6

142.9 ± 110.2

0.160

Albumin (g/L)

41.9 ± 3.2

42.0 ± 3.1

41.5 ± 3.5

0.192

PNI

52.0 ± 4.9

52.1 ± 4.7

51.6 ± 5.3

0.334

SMA (cm2)

84.5 ± 29.9

88.4 ± 30.3

75.9 ± 27.3

< 0.001

SMI (cm2/m2)

31.0 ± 10.3

32.4 ± 10.5

27.8 ± 9.0

< 0.001

  1. RDW Red blood cell distribution width, AD Adenocarcinoma, SCC Squamous cell carcinoma, BMI Body mass index, NLR Neutrophil-to-lymphocyte ratio, PLR Platelet-to-lymphocyte ratio, RDW Red blood cell distribution width, PNI Prognostic nutritional index, SMA Skeletal muscle area, SMI Skeletal muscle index